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ABSTRACT
Escherichia coli DEAD-box protein A (DbpA) is an
ATP-dependent RNA helicase with specificity for
23S ribosomal RNA. Although DbpA has been
extensively characterized biochemically, its biolo-
gical function remains unknown. Previous work has
shown that a DbpA deletion strain is viable with little
or no effect on growth rate. In attempt to elucidate a
phenotype for DbpA, point mutations were made at
eleven conserved residues in the ATPase active
site, which have exhibited dominant-negative phe-
notypes in other DExD/H proteins. Biochemical
analysis of these DbpA mutants shows the expected
decrease in RNA-dependent ATPase activity and
helix unwinding activity. Only the least biochemi-
cally active mutation, R331A, produces small colony
phenotype and a reduced growth rate. This domi-
nant slow growth mutant will be valuable to
determine the cellular function of DbpA.
INTRODUCTION
DbpA is an Escherichia coli DEAD-box protein that
binds tightly and speciﬁcally to 23S rRNA and stimulates
rapid ATP hydrolysis (1,2). Extensive truncation (2–4)
and footprinting (5) experiments have shown that DbpA
binds to a 153nt region (153-mer) of 23S rRNA consisting
of helices 89 through 93, which are all part of the
peptidyltransferase center (PTC) of the ribosome. Shorter
fragments that contain only hairpin 92 bind to DbpA with
similar aﬃnity as the 153-mer, demonstrating this hairpin
as the primary binding site (3). In the presence of RNA
duplexes containing hairpin 92, DbpA demonstrates
weakly processive 30 to 50 RNA helicase activity (6).
However, mature ribosomes are poor substrates for DpbA
because hairpin 92 is buried within the PTC (4).
The N-terminal 381 amino acids of DbpA contains the
ATPase core, 9 conserved motifs spanning two domains
that deﬁne DExD/H proteins and are responsible for
the ATP binding and hydrolysis activities. The C-terminal
76 amino acids form a basic domain that forms an
RNA recognition motif (RRM) and is involved in
RNA-binding speciﬁcity (7). The isolated C-terminal
domain of YxiN, the Bacillus subtilis ortholog of DbpA,
can bind hairpin 92 tightly and speciﬁcally (5). However,
the isolated N-terminal domain of YxiN binds RNA
weakly and nonspeciﬁcally but does show ATPase
activity, thus demonstrating the functional modularity of
this DExD/H protein (5).
Despite this extensive biochemical characterization,
relatively little is known about the function of DbpA in
E. coli. DbpA mRNA levels are found in low amounts in
logarithmic cells, but they increase upon acid shock,
addition of ciproﬂoxacin and at stationary phase (8).
Several groups have deleted the dbpA gene using diﬀerent
methods, however no growth defects were observed in
diﬀerent culture media and growth conditions (9,10)
(Tsu,C. and Uhlenbeck,O.C., unpublished data). Because
DbpA is activated by 23S rRNA in vitro, it was
hypothesized that DbpA is either involved in the ribosome
assembly pathway or in some specialized aspect of
translation (2). Under many growth conditions, DbpA is
not essential and therefore, either one of the other E. coli
DExD/H proteins can substitute for its function or it is
only required under certain growth conditions.
The goal of this article is to identify a dominant
negative mutant of DbpA that can be used to better
understand its cellular function. DbpA is a good candidate
for creating a dominant negative mutant because its
binding aﬃnity and speciﬁcity lies almost completely in
the CTD, while its ATPase and helicase activity are
determined by the conserved ATPase core (5). These
modular characteristics make it possible to inactivate
DbpA by mutating catalytic residues without aﬀecting the
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knockout mutation of DbpA, a site-directed mutation
would produce a protein that could compete with
wild-type DbpA for the rRNA-binding site and subse-
quently block action at the normal site of function.
Therefore, several point mutations were made in the
conserved sequence motifs of DbpA that were identical to
those showing dominant negative properties in other
DExD/H proteins, including eIF-4A, Prp16, Prp22,
Prp28, Prp43, Rok1p, Sub2p, Ded1p and Dbp8p (11–19).
MATERIALS AND METHODS
Site-directed mutagenesis and purification
ofHis-tagged DbpAmutations
The gene coding for DbpA with an N-terminal Met-His6
sequence was cloned into the pET-3a vector between
the NdeI and BamHI sites (20). Site-directed mutagenesis
was performed on this plasmid using QuikChange

XL Site-Directed mutagenesis kit (Stratagene). DbpA-
containing plasmids were transformed into BL21(DE3)
pLysS cells (Stratagene) and puriﬁed as previously
described (20) with the following changes. Cell lysate
was puriﬁed by FPLC over a nickel column or by batch
puriﬁcation over Ni-NTA beads (Qiagen) in buﬀer A
(500mM NaCl, 20mM MOPS pH 7, 1mM b-mercapto-
ethanol, 10% glycerol) and 10mM imidazole. His6-DbpA
was eluted in buﬀer A with 300mM imidazole and further
puriﬁed using a Pharmacia Superdex75 sizing column
in buﬀer A.
Preparation ofRNA
Native E. coli rRNA (16S and 23S) was from Roche
Diagnostics or puriﬁed from E. coli MRE600 cells by
the following method. The cell pellet was thawed on
ice and resuspended in ribosome lysis buﬀer (50mM Tris
pH 7.5, 10mM MgCl2, 100mM NH4Cl, 0.5mM EDTA
pH 8, 6mM DTT) and RQ1 DNase (Promega). Cells
were lyzed by a Thermo IEC french press and cell debris
removed by centrifugation for 20min at 11000r.p.m.
in an Eppendorf table top centrifuge. Ribosomes were
collected by centrifugation for 1h at 40000r.p.m. in
a Ti45 rotor in a Beckman Optima LE-80K ultracen-
trifuge. The pellet was cleared by rinsing with TE buﬀer
and then resuspended in SDS–Urea extraction buﬀer
(6M Urea, 0.1% SDS, 10mM Tris pH 7.8, 10mM
EDTA pH 8, 350mM NaCl). Ribosomal RNA was
puriﬁed by phenol–chloroform extraction, ethanol pre-
cipitation, LiCl precipitation, a second ethanol precipita-
tion and elution over NAP-25 columns (Amersham
Biosciences).
The 9-mer and 32-mer RNA were purchased from
Dharmacon. A 153-mer segment of domain V of 23S
rRNA was prepared by in vitro transcription. The 153-mer
DNA template was PCR ampliﬁed from p2454 to 2606
(4) and puriﬁed with the QIAquick Gel Extraction kit
(Qiagen). Transcription of 153-mer RNA was carried out
in transcription buﬀer (80mM Tris pH 7.5, 20mM DTT,
4mM Spermidine, 0.1% TritonX, 12mM MgCl2, 0.004U/
ml pyrophosphatase) with 4mM NTP’s, 15ng/ml template
DNA and 0.1mg/ml T7 RNA polymerase at 378C for 3h,
concentrated by ethanol precipitation and then puriﬁed by
10% PAGE. RNA was extracted from the gel by passive
elution (0.5M NaOAc and 1mM EDTA pH 8) overnight
at 48C and then concentrated by ethanol precipitation.
The concentration of the ﬁnal product was calculated
using "260=1.3 10
6L/molcm. RNA substrates were
50-
32P labeled with polynucleotide kinase and g-
32P ATP
and puriﬁed by 10% denaturing PAGE. Labeled RNA
was extracted from the gel by passive elution overnight at
48C and then precipitated with ethanol.
Assays
The rate of ATP hydrolysis of DbpA in the presence
of 23S+16S rRNA was measured using the previously
described high-throughput coupled spectroscopic assay
(5). All reported values are the average of at least three
data sets and are all within 2-fold error.
The binding of DbpA to a 153-mer portion of 23S
rRNA was determined based on the previously described
gel shift assay (21). Binding reactions were carried out
in binding buﬀer (50mM HEPES pH 7.5, 5mM MgCl2,
100mM KCl, 100mM DTT, 100mg/ml BSA and 5% (v/v)
glycerol) with 200pM 50-
32P RNA, 70mM polyA and
increasing amounts of DbpA protein. Samples (20ml)
were equilibrated at 248C for 30min and then an 18ml
aliquot was loaded on a 5% native acrylamide gel (29:1
acrylamide:bis) running at 200V in 1/3 TBE buﬀer. Gels
were run for 2h, dried and exposed to a phosphor
screen. The fraction of bound protein was determined
from the ratio of counts in the bound RNA band relative
to the total counts of the free and bound RNA.
The fraction of bound RNA versus DbpA concentration
was plotted and ﬁt to simple binding equilibria to
determine the dissociation constant (Kd) (21). The
binding aﬃnity was also evaluated in the presence of a
non-hydrolyzable ATP analog, AMPPNP. Reactions were
carried out as above with 50pM 50-
32P RNA and the
addition of 4mM AMPPNP. All reported values are
the average of at least three data sets and are corrected
for percent activity as measured by a stoichiometric
binding assay (described below). The errors are less than
2.5-fold for all measurements.
The stoichiometry of RNA binding for each wild-type
and mutant protein was measured using the gel shift
binding assay in the presence of 500nM 50-
32P 153-mer
and varying protein concentrations (21). The fraction of
bound RNA versus protein concentration was plotted
and ﬁt linearly (data not shown). The linear slope is the
percent active protein, which is then multiplied by
the average value of Kd to obtain ﬁnal values corrected
for percent protein activity.
Helicase activity was measured using a 50-
32P labeled
9-mer (
 9-mer) annealed 50 to 32-mer RNA containing
hairpin 92 (Figure 4A) using the assay described in Diges
et al. (22) with the following modiﬁcations. A total of
1.2mM 32-mer and 0.6mM
 9-mer were annealed by
mixing in 50mM HEPES pH 7.5 and 50mM KCl
and then heating to 958C for 1min, 808C for 1min,
758C for 2min, 708C for 3min. At 708C, 5mM MgCl2 was
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and then to 48C and used immediately. Helicase assays in
the presence of excess protein were based on the
previously described method in Ref. (22) and carried out
at 248C in binding buﬀer (as above). Seventy-ﬁve
microliter aliquots of the RNA mixture (5nM annealed
substrate with 70mM polyA) and protein mix (0.6mM
DbpA, 2mM ATP, 2mM MgCl2) were combined to
initiate unwinding. At various times, 9ml of the reaction
mixture was removed and mixed with 3ml of quench
dye [2.5mM EDTA pH 8, 0.025% SDS (w/v), 1.25%
glycerol (v/v), pinch xylene cyanol]. Then 9ml of the
quenched reaction was immediately loaded onto a 10%
native acrylamide gel (29:1 acrylamide:bis) running
at 150V in 1/3  TBE buﬀer at 248C. Gels were run at
200V for 2h, dried and exposed to a phosphor screen.
The fraction of bi-substrate (
 9-mer+32-mer) was
determined from the ratio of counts in the displaced
RNA band (
 9-mer alone) relative to the total counts of
the annealed and displaced RNA bands. The fraction of
duplex RNA was plotted versus time and ﬁt to a single
exponential curve. All reported rates of unwinding
represent the average of at least three measurements and
the error is within 2-fold.
Western blots
XL10-Gold

(Stratagene) or Tuner
TM
(DE3)pLacI
(Novagen) modiﬁed to be RecA
  (a gift from M.E.
Saks) cells were transformed with wild-type or mutant
plasmids. Overnight cultures were diluted in LB, grown
to OD600   0.3–0.4, then the cells were harvested,
quick-cooled by pouring over an equal volume of ice
and centrifuged. Cells were lyzed as described by
J. Choralis et al. (23) except the lysis buﬀer contained
20mM HEPES pH 7.5, 30mM NH4Cl, 10mM MgCl2
and 4mM b-mercaptoethanol. Clariﬁed lysates were
diluted in lysis buﬀer plus 5 SDS load dye (85mM
Tris–HCl pH 6.8, 4% SDS, 40% glycerol, 10%
b-mercaptoethanol, bromophenol blue) and then
10–25ml were loaded on a 15% Tris–HCl Ready gel
(Bio-Rad). Gels were transferred to PVDF (Bio-Rad)
membrane in transfer buﬀer, 25mM Tris–HCl pH 8.3,
192mM glycine, 20% methanol and 0.1% SDS, at 100V
for 1h at 48C. PVDF membranes were treated according
to the Li-Cor Odyssey

manual, probed with a 1:10000
dilution of rabbit anti-DbpA (provided by F. Fuller-Pace)
and a 1:5000 dilution of secondary antibody Alexa
Fluor

680 goat anti-rabbit IgG (H+L) (Invitrogen)
and then scanned on the Odyssey

Infrared Imaging
System, which can report relative intensities of each
band on the blot. The number of moles of each protein
was estimated using a standard curve based on the
band intensities for a serial dilution of puriﬁed DbpA
protein. Molecules per cell were estimated using
the number of moles divided by the approximate
amount of cells (according to the volume collected
and lyzed) and loaded on the blot. Due to the small
amount of endogenous DbpA, 40 times more of
wild-type Tuner
TM
(DE3)pLacI RecA
  cells were loaded
compared to those containing DbpA and mutant
plasmids.
RESULTS
DbpAmutant design
Mutations were focused in regions of the protein
expected to be involved in ATP binding and hydrolysis
in order to disrupt the activity of DbpA without
aﬀecting its substrate binding. Although the complete
structure of DbpA is not available, the structures of the
C-terminal half of the ATPase core and the CTD of
the B. Subtilis ortholog, YxiN, are known (7,24). The
C-terminal half of the ATPase core forms a parallel
ab-fold as in other RNA helicase structures (25–29) and
RecA (24,27,30), while the C-terminal domain (CTD)
structure as mentioned above forms a RRM-fold and is
responsible for RNA binding and speciﬁcity (7). The
structure of a closely related DEAD-box family
member, Drosophila Vasa, in complex with single-
stranded RNA and a non-hydrolyzable ATP analog,
helps to identify the likely critical catalytic residues of
DbpA (Figure 1). In addition, extensive biochemical
characterization of ATPase core mutations in human
eIF-4A and yeast Prp16, Prp22 and Prp43 have
been reported (31,32). Finally, several mutations in the
ATPase active sites of yeast eIF-4A, Prp16, Prp22, Prp28,
Prp43, Rok1p, Sub2p, Ded1p and Dbp8p were previously
found to have dominant negative phenotypes (11–19).
Therefore, mutational analysis of DbpA was designed
according to the structures, focusing on residues that
contact ATP, and based on the other RNA helicase
mutations that caused dramatic biochemical diﬀerences or
dominant negative phenotypes.
Eleven DbpA residues that span four conserved
motifs (I, II, III, VI) were mutated to alanine. Motifs I,
II and III are in the N-terminal RecA-like domain of the
catalytic core, (N-Rec) and motif VI lies in the C-terminal
RecA-like domain of the core (C-Rec) (Figure 1). In the
GSGKT sequence of motif I, also known as the Walker
A motif, the conserved lysine (K53) hydrogen bonds with
the b and g phosphates of ATP, whereas the threonine
(T54) coordinates a Mg
2+ ion that also interacts with
the b and g phosphates (26,30). In the DEAD sequence of
motif II, the Walker B motif, the highly conserved
aspartate (D153) and glutamate (E154) residues also
coordinate the Mg
2+ ion that interacts with the b and g
phosphates of ATP (26,30) and are responsible for
hydrolysis (33). The last aspartate (D156) makes inter-
domain contacts with motif III (26,30). The serine (S184),
alanine (A185) and threonine (T186) residues that form
motif III do not interact directly with ATP, but are
thought to coordinate ATP binding and helicase activ-
ities (31). In the HRIGRTAR sequence, motif VI, the
second arginine (R331) interacts with the g phosphate
of ATP, while the third arginine (R334) interacts with the
a, b and g phosphates (26,30,33). One of the arginines that
contacts the g phosphate is proposed to be an ‘arginine
ﬁnger’ that is involved in transition state stabilization
Nucleic Acids Research, 2008, Vol. 36, No. 1 43during hydrolysis and may be critical for coupling the
ATPase cycle with helicase activity (26,30,33,34).
RNA binding
The majority of DbpA’s RNA-binding aﬃnity is derived
from the interactions of the CTD (5), therefore mutants
in the ATPase motifs are not expected to signiﬁcantly
aﬀect binding. A native gel electrophoretic mobility shift
assay was used to evaluate the binding aﬃnity (Kd)
of wild-type DbpA and the eleven mutants for the 153-nt
fragment of 23S rRNA (21). In agreement with other
experiments (21), the binding aﬃnity for wild-type DbpA
is 1.7nM and, as expected, most of the mutant
proteins bind to substrate RNA with similar aﬃnities
(Figure 2 and Table 1). Surprisingly, the Kd for two of the
mutants, D153A and R328A is approximately 10-fold
weaker than wild-type (Table 1). As with all the
mutants, the CTD is likely to remain unchanged, so
these two mutations must aﬀect the overall structure
of DbpA thereby, causing the decrease in binding aﬃnity.
In the presence of saturating amounts of non-hydrolyz-
able ATP (AMPPNP), DbpA’s binding aﬃnity for
153-mer RNA is 8.5-fold tighter (Figure 2) (21). This
additional RNA-binding aﬃnity is thought to be due to
interactions with the catalytic domains that only form
when their structure is pre-organized by the binding
of ATP (21). The RNA-binding aﬃnity of each mutant
was measured in the presence of 153-mer and AMPPNP
to determine whether they have this additional aﬃnity
(Table 1). Most of the mutants displayed little or no
increase in aﬃnity when AMPPNP was present (Table 1)
indicating that their ATP-binding site is either partially
or fully disrupted thus preventing the additional
contacts with the RNA. Only two of the mutants, K53A
and D156A, show a greater than 5-fold increase in
RNA-binding aﬃnity in the presence of AMPPNP,
R331
R334 H327
R328
AMPPNP
K53
T54
S184
T186
E154
D153
D156
A
B
Domain 1 (N-Rec) Domain 2 (C-Rec)
F Q I Ia Ib II III IV V VI CTD
TGSGKT DEAD SAT HRIGRTAR
Figure 1. (A) Conserved ATPase core motifs with conserved DbpA sequences shown below the corresponding motif. Residues mutated in this study
are in bold. (B) Drosophila Vasa RNA Helicase ATP-binding pocket structure (PDB:2db3) showing only the residues that were mutated in DbpA
(E. coli DbpA numbering). Colors coordinate to the motifs are as in Figure 1A; motif I is purple, motif II is red, motif III is yellow, motif VI is cyan
and AMPPNP is green. The white sphere is the Mg
2+ that is coordinated to the AMPPNP. Important contacts deﬁned in the Vasa structure are
indicated with a dashed line.
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Figure 2. RNA-binding curves for wild-type DbpA (circles and solid
line), H327A (triangles and dashed line), R334A (squares and dotted
line) and wild-type DbpA with 4mM AMPPNP (open circles and
solid line) derived from gel mobility shift assays. All experiments are
performed with 200pM 50-
32P labeled 153-mer RNA in binding buﬀer
[50mM HEPES pH 7.5, 5mM MgCl2, 100mM KCl, 100mM DTT,
100mg/ml BSA, 5% (v/v) glycerol] and 70mM polyA at 248C.
44 Nucleic Acids Research, 2008, Vol. 36,No. 1suggesting that their ATP-binding site remains nearly fully
intact (Table 1).
RNA-dependent ATPase activity
The ATPase activity of each mutant protein was
initially assayed in the presence of 250nM 23S rRNA
and 5mM ATP which are saturating for wild-type DbpA.
For each mutation, the measured hydrolysis rate was
plotted versus concentration of protein to determine the
speciﬁc activity, kobs. For all of the mutants, kobs values
were signiﬁcantly reduced compared to wild-type, with
the activities ranging from <5% to  70% active (Table 2).
The mutants with high speciﬁc activity (D156A, S184A,
T186A and H327A) make interdomain contacts but do
not contact the ATP directly (Figure 1B), suggesting
that they are not directly involved in hydrolysis (30). The
two mutants with the lowest speciﬁc activity, R331A
and K53A, both contact the phosphates of the ATP
directly (26). This lysine is invariant in all ATPases, and
when mutated usually abolishes hydrolysis and unwinding
(Figure 1B) (33). As expected, the K53A mutant of DbpA
shows very weak ATPase activity (kobs=0.7min
 1).
Interestingly, K53A still demonstrates increased RNA-
binding aﬃnity in the presence AMPPNP suggesting
that the mutation aﬀects catalysis without aﬀecting ATP
binding (Tables 1 and 2). It has been proposed that one
of the arginines in motif VI acts as an ‘arginine ﬁnger’
that stabilizes the transition state of the hydrolysis
reaction and connects domain two to the ATP bound in
domain one (30). In DbpA, R331 is the likely ‘arginine
ﬁnger’ due to the very low ATPase activity
(kobs=0.4min
 1) of the mutant. Alanine substitutions
of the other two arginines in motif VI of DbpA, R328
and R334, have more ATPase activity than R331A and
thus are less likely to serve as the arginine ﬁnger. In
addition, R328 does not seem to bind the ATP in the
crystal structure of Vasa (Figure 1B) (26).
Four mutants, D156A, S184A, T186A and H327A,
have suﬃcient ATPase activity to allow the determination
of the apparent RNA-binding constant, Kapp, RNA, the
maximum catalytic rate, kmax and the Michaelis–Menten
constants, KM, ATP and kcat. Here, Kapp, RNA and kmax
were measured with 5mM ATP and RNA concentration
between 0 and 500nM (Figure 3A), whereas the
Michaelis–Menten values are measured at 250–500nM
RNA with ATP concentration between 0 and 4mM
ATP (Figure 3B). As had been determined previously,
wild-type DbpA has a very tight Kapp, RNA of 33nM
(Table 2) (4). The mutants D156A, S184A and T186A
all have apparent binding constants within 2.5-fold of
wild-type (Table 1 and Figure 2), indicating that they
bind substrate RNA equally well. This conclusion is
consistent with the gel mobility shift data for these
mutants, except for H327A, which has a 6-fold higher
Kapp, RNA even though the Kd is similar to wild-type
(Tables 1 and 2). This discrepancy could be due to the
weaker ATP binding of this mutant or just an artifact of
the indirect measurement of RNA binding using the
ATPase assay.
The Michaelis–Menten constant for wild-type DbpA
(KM, ATP=400mM) is consistent with a previous
measurement (Table 2 and Figure 3B) (4). KM, ATP
values for T186A and H327A are moderately weaker than
wild-type DbpA, while mutant D156A shows a slightly
tighter KM, ATP than wild-type, suggesting that it may
bind ATP better (Figure 3B, Tables 1 and 2). These data
are all consistent with gel mobility shift data in the
presence of AMPPNP described earlier. The two mutants
that fail to bind ATP in this assay do not increase in
aﬃnity for RNA when AMPPNP is present in the gel
shift assay. The D156A mutant has a tighter KM, ATP,
which is also reﬂected by the 20-fold increase in
binding aﬃnity when AMPPNP is present compared
with the 10-fold increase for wild-type DbpA (Table 1).
Table 1. Binding aﬃnities for wild-type and the eleven DbpA mutants
to 153-mer RNA in the absence and presence of 4mM AMPPNP
Motif Protein Kd RNA (nM) Kd RNA+AMPPNP
(nM)
wild-type 1.7 0.2
I K53A 2.4 0.4
T54A 2.8 4.0
II D153A 14 14
E154A 5.0 3.4
D156A 1.9 0.1
III S184A 2.8 1.5
T156A 1.8 0.9
VI H327A 1.5 0.7
R328A 18 18
R331A 2.3 0.8
R334A 1.1 0.4
Dissociation constants (Kd) were determined from data such as those
presented in Figure 2.K d RNA values are corrected for percent active
protein and are averages of at least three determinations which vary by
less than 2.5-fold.
Table 2. ATPase activities of wild-type and the eleven DbpA mutants
in the presence of 23S rRNA substrate and ATP
Motif Protein kobs
(min
 1)
kmax
(min
 1)
Kapp,RNA
(nM)
kcat
(min
 1)
KM,ATP
(mM)
wild-type 120 140 33 160 400
I K53A 0.7 – – – –
T54A 6.0 – – – –
II D153A 1.7 – – – –
E154A 2.0 – – – –
D156A 28 31 98 19 64
III S184A 53 68 44 59 410
T156A 79 97 64 87 1000
VI H327A 50 82 210 58 2600
R328A 1.1 – – – –
R331A 0.4 – – – –
R334A 14 – – – –
The kobs is the slope of a plot of the rate of ATP hydrolysis versus
protein concentration at constant ATP (5mM) and RNA (250–500nM)
at 248C. The Kapp,RNA, kmax, KM,ATP and kcat for D156A, S184A,
T186A and H327A were determined from data such as presented in
Figure 3. Values are averages of at least three data sets and are within
2-fold error.
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case of S184A, which binds ATP equally well as wild-type
(KM, ATP=410mM) but does not show an expected
increase in aﬃnity for RNA in the presence of AMPPNP
in gel shift assays (Tables 1 and 2).
RNA helicase assay
The RNA substrate used in the helicase assay contains a
32nt oligomer containing hairpin 92 annealed to a 50-
32P
labeled 9-mer (Figure 4A) (22). In the presence of
saturating (2mM) ATP, wild-type DbpA unwinds the
substrate at a rate of 2.2min
 1 (Figure 4B). As expected,
the majority of the mutants that hydrolyze ATP poorly;
K53A, D153A, E154A, R328A and R331A are unable
to unwind the duplex RNA substrate (Table 3). However,
T54A, D156A, S184A, T186A and H327A, which have
kobs greater than  6min
 1, can unwind the RNA duplex
at varying rates. Interestingly, R334A has a higher kobs of
14min
 1 ( 12% active), but cannot unwind the duplex
(Figure 4B, Tables 1 and 3). In the structure of Drosophila
Vasa, the equivalent Arginine (R582) seems to contact
all phosphates of the AMPPNP (26). It is possible that
this residue is more involved in release of ATP and
coordination of the hydrolysis to helicase action, which
would result in this uncoupling of activities.
Growthphenotype
The wild-type dbpA gene was cloned into the pET-3a
system (Novagen) where the target genes are under the
control of the T7 RNA polymerase promoter (20). Eleven
point mutations were made using this dbpA-containing
plasmid and Stratagene’s QuikChange

XL Site-Directed
mutagenesis kit. Plasmids were initially transformed into
the T7-lacking E. coli XL10-Gold strain (Stratagene).
When mutant DbpA plasmids were transformed into
XL10-Gold, all eleven strains behaved the same as wild-
type DbpA and wild-type XL10-Gold controls. In order
to produce protein for biochemical studies, the same
eleven plasmids were transformed into E. coli BL21(DE3)
pLysS (Stratagene), which harbors a T7 RNA polymerase
gene under control of the lac repressor. During the course
of this experiment, we noticed that strains containing the
R331A mutant plasmid consistently produced a small
colony phenotype while the other ten strains showed
colony sizes similar to controls [BL21(DE3) pLysS with
wild-type DbpA plasmid and BL21(DE3) pLysS
expressing endogenous levels of DbpA]. This small
colony phenotype for R331A is only seen in cells
containing the T7 RNA polymerase gene and is likely
the result of ‘leaky’ expression of the mutant from the
plasmid (35). Presumably, the nonfunctional R331A
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endogenous DbpA to produce the small colony pheno-
type. It is striking that none of the other DbpA
mutations show the small colony phenotype, even when
cells are plated at 248C instead of 378C because mutations
in DExD/H proteins are often cold sensitive (23,36,37).
This may reﬂect the fact that of the eleven mutations
tested, R331A shows the lowest amount of ATPase
activity (Table 1). To conﬁrm that the small colony
phenotype was a consequence of the R331A point
mutation, the mutation was made a second time with
identical results.
Two additional growth experiments support the
idea that the small colony phenotype results from
competition between the R331A protein and the endo-
genous wild-type DbpA. First, when the R331A plasmid is
transformed into E. coli BL21(DE3) cells, even smaller
colonies are observed, consistent with an even greater
amount of ‘leaky’ plasmid expression in the absence of
the pLysS gene encoding the T7 lysozyme, which inhibits
T7 RNA polymerase (38). Second, when the R331A
plasmid is transformed into an E. coli BL21(DE3) strain
with a deletion of the DbpA gene (provided by I. Iost),
even smaller colonies were observed, which is expected
when the competing wild-type protein is unavailable.
Finally, if T7 RNA polymerase is induced by the addition
of 1mM IPTG to any of the strains discussed above,
there is no signiﬁcant change in the results. Presumably,
the relatively large amount of ‘leaky’ expression from the
plasmid-encoded gene is more than suﬃcient to compete
with the wild-type protein.
Further analysis of the R331A mutant in BL21(DE3)
pLysS cells was complicated by the fact that when cells
were grown in liquid culture for many hours, and then
plated, the colony size was no longer homogenously small.
Instead, a signiﬁcant fraction of larger colonies was
observed. This phenotypic instability is probably the
result of recombination between the mutant plasmid
gene and the genomic copy of the DbpA gene. Thus, the
R331A plasmid and several other mutations were
transformed into a Tuner
TM
(DE3) pLacI RecA
  strain.
In this case, the small colony phenotype of R331A still
occurs (Figure 5A) and is much more stable at both 228C
and 378C. When the R331A mutation in Tuner
TM
(DE3)
pLacI RecA
  was grown in liquid culture at both
temperatures, it had a modestly slower growth rate
(1.6-fold at 378C, 2.2-fold at 228C) than either the wild-
type DbpA or the empty vector control (Figure 5B).
In addition, at both temperatures, cells harboring the
R331A mutation took signiﬁcantly longer to exit sta-
tionary phase and enter log phase (Figure 5B).
To compare the expression of uninduced R331A
mutant with that of endogenous DbpA, semi-quantitative
western blot experiments using a polyclonal antibody
against DbpA (provided by F. Fuller-Pace) were per-
formed on the R331A mutant and wild-type DbpA
expressed in Tuner
TM
(DE3) pLacI RecA
  along with
Table 3. Unwinding rates of wild-type and the eleven DbpA mutants
Motif Protein Unwinding rate (min
 1)
wild-type 2.2
I K53A <0.1
T54A 0.1
II D153A <0.1
E154A <0.1
D156A 0.4
III S184A 0.8
T156A 0.2
VI H327A 0.3
R328A <0.1
R331A <0.1
R334A <0.1
Unwinding rates were determined from data such as those presented in
Figure 4 and are the averages of at least three separate determinations
that vary by less than 2-fold.
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Figure 5. (A) Wild-type DbpA and mutants K53A and R331A in
Tuner
TM (DE3) pLacI RecA
  cells at 378C. (B) Growth rates and
doubling times at 228C for DbpA (circles, 113min), K53A (squares,
134min) and R331A (triangles, 251min) in Tuner
TM (DE3) pLacI
RecA
  cells (M.E. Saks). Doubling times are an average of 3–4 growth
experiments.
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TM
(DE3) pLacI RecA
  and wild-type
Tuner
TM
(DE3) pLacI RecA
  controls (Figure 6). The
amount of endogenous DbpA present in wild-type
cells cannot be detected even when large amounts of
lysate are analyzed. Based upon the detection limit of the
DbpA antibody, we estimate that there are less than 1000
molecules of DbpA per cell. However, when plasmids
containing wild-type DbpA, R331A or K53A are present,
much larger amounts of protein were observed. Based on
three separate experiments  75000 copies per cell could
be estimated for all three proteins. This high level of
expression is observed as the result of ‘leaky’ expression
from T7 RNA polymerase (35) compounded by the
multiple copies of the plasmid. Because the amount of
R331A protein is not signiﬁcantly diﬀerent from the
others, its small colony phenotype is not due to the
presence of a larger or smaller amount of protein.
Furthermore, the 75-fold excess of R331A mutant protein
over endogenous DbpA protein means that it can
eﬀectively compete for the available 23S rRNA hairpin
92 binding site, despite the fact that in the presence of
ATP it binds less well than wild-type DbpA.
DISCUSSION
The mutations in the active site of DbpA possess
similar biochemical properties as those observed in several
other DExD/H proteins including, human eIF-4A, yeast
Prp16, Prp22, Prp43 (12,31,32). The classic ATPase
motifs I and II, also known as the Walker A and B
motifs, are highly conserved and important in the ATP
hydrolysis cycle (30,33). In DbpA, alanine substitution of
the strictly conserved residues of these motifs (K53, T54,
D153 and E154) causes drastic reductions in ATP
hydrolysis rates and helicase activities as expected.
Residue K53 of motif I is expected to make contacts
with the b and g-phosphates of ATP and, when mutated in
DbpA, kobs is low (0.7min
 1) and helicase activity is
abolished. According to crystal structures and other
mutagenesis data, motif II residue E154 coordinates a
Mg
2+ ion while the D153 residue binds to the ATP
through that Mg
2+ and is proposed to catalyze hydrolysis
of the b g phosphate bond (30,33). Similar mutation of
all these residues to alanine in yeast Prp22, Prp16 and
Prp43, as well as more conservative mutation to
other residues in human eIF-4A, also show little to no
ATPase and no RNA helicase activity (12,31,32). In
contrast with the Walker A and B residues, crystal
structures of Vasa show that the last residue of motif II,
D156, does not contact the ATP but instead makes
interdomain contacts with the H327 of motif VI (26). In
DbpA, D156A is the only mutant from these two
motifs that has signiﬁcant ATPase activity and moderate
helicase activity as also shown with similar mutations
of this last residue (D/H) in HCV NS3, human eIF-4A,
and yeast Prp16 and Prp43 (12,31,32,39).
Motif III does not contact ATP directly but makes
important interdomain contacts, i.e. S184 and T186
contact D156 in motif II and T186 contacts H327 in
motif VI, which most likely assists in domain closure
(26). Individual mutations of S184 and T186 to alanine
in DbpA only moderately decrease helicase and
ATPase activity similar to Prp16 and Prp43 (12,32).
However, simultaneous mutations of the serine and
threonine in motif III of human eIF-4A causes a small
decrease in ATP hydrolysis while almost completely
abolishing unwinding, suggesting this motif is coupling
the ATPase and helicase activities (31).
Motif VI, unlike motifs I, II and III, is found in
domain 2, along the ATP-binding pocket at the interface
of the two domains (Figure 1B). As mentioned above,
H327 makes contacts to domain 1 and to motif III (26)
and its mutation to alanine in DbpA, like the other
interdomain contacting mutants, (D156A, S184A and
T186A) only moderately aﬀects the ATPase and helicase
activities. However, individual mutations of each of the
three arginines all have severe eﬀects on ATPase and
helicase activity as seen with yeast Prp16, Prp 22
and human eIF-4A (21,32). Two of these arginines in
the Vasa structure, R331 and R334, make contacts with
the ATP (Figure 1B) (26) and when mutated to alanine
in DbpA, kobs decreases to <12% of wild-type for R334A
and <0.5% of wild-type for R331A (Table 2). The ﬁrst
arginine of motif VI, R328, does not contact the ATP
but also has severely decreased ATPase activity when
mutated in DbpA (Figure 1B and Table 2). The reduced
binding aﬃnity of the R328A mutant might explain
the low kobs (Tables 1 and 2) but it is unclear why the
binding is aﬀected. One of the arginines in motif VI is
thought to act as an ‘arginine ﬁnger’, important in
transition state stabilization of the ATP hydrolysis
cycle (30,33,34). Out of the three arginine mutations in
DbpA, the R331A mutant has the most dramatic eﬀect,
with no helicase activity, and the lowest kobs of 0.4min
 1
(Tables 2 and 3). Therefore, we propose that R331 is most
likely to act as the ‘arginine ﬁnger’ in DbpA.
The DbpA R331A mutant is also the only one of the
eleven ATPase mutants that displays a dominant negative
phenotype (Figure 5). It is interesting to compare its
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48 Nucleic Acids Research, 2008, Vol. 36,No. 1biochemical properties to the K53A mutation, which does
not display a phenotype. In other DExD/H helicases,
yeast Prp16, Prp22, Prp43 and human and yeast eIF-4A,
mutations in either of the amino acids corresponding to
K53 or R331 result in lethal or dominant negative
phenotypes and greatly reduced ATPase and helicase
activities (11–14,31,32). In DbpA, the severely decreased
ATPase activity for R331A and K53A are nearly the same
(0.4 and 0.7min
 1, respectively) and both show no
helicase activity (Tables 2 and 3). They both can bind
substrate well (Table 1) and therefore both should block
the binding and activity of the wild-type protein in vivo.
Why then does only the R331A mutation show a
phenotype? The only major biochemical diﬀerence
between the two mutant proteins is that K53A binds
RNA substrate 6-fold tighter in the presence of AMPPNP,
similar to wild-type DbpA, where the R331A-binding
aﬃnity for RNA is only 3-fold tighter when AMPPNP is
present (Table 1). This would suggest that the K53A
mutation would be more eﬀective than the R331A
mutation in competing with wild-type protein in vivo
where ATP is present. Thus a more likely explanation of
this caveat lies in the speciﬁc activities of the two mutant
proteins. It could be that the slightly higher residual
ATPase activity of the K53A mutation is suﬃcient to
permit the catalytic cycle and substrate rearrangement
to occur and thus avoid the phenotype. In contrast,
the R331A mutation eliminates the ‘arginine ﬁnger’, which
thereby removes the ATP-dependent interdomain motion
that is critical for helicase function (34).
Until now, there has not been an available DbpA
phenotype. This dominant slow growth mutation will be
extremely useful to further investigate the molecular
function of DbpA (2). From what is known thus far,
DbpA is expected to be important in some role of
ribosome biogenesis or translation because it interacts
with the 23S rRNA at the peptidyltransferase center.
Initially, it will be interesting to study the ribosome
populations in the mutant strains to hopefully begin to
understand the actual function of DbpA in vivo.
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